3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay was used to determine cell viability. LNCaP and PC3 cells were seeded in 96-well plates and incubated at 37oC, 5% CO2 to allow exponential growth. Medium was then replaced by fresh medium containing drugs, oleic acid, or antibodies at the required concentrations in triplicate wells. MTT was added to a final concentration of 0.5 mg/mL and incubated for 2 hours. Cells were then solubilized by addition of DMSO and the absorbance read at 570 nm using a Tecan M2000 plate reader.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.